Logotype for Sunway Berhad

Sunway (SUNWAY) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Sunway Berhad

Q4 2025 earnings summary

30 Jul, 2026

Executive summary

  • FY2025 revenue rose 24.5% YoY to RM9.81 billion, with Q4 FY2025 revenue declining 18.8% YoY to RM2.32 billion; profit before tax for FY2025 increased 23.0% to RM1.87 billion, and Q4 PBT surged 41.5% to RM698 million, driven by strong performance in construction, property development (notably from Sunway MCL/HLMCL acquisition and negative goodwill), and healthcare.

  • Net profit attributable to owners for FY2025 was RM1.30 billion, up 13% YoY; PATMI for Q4 FY2025 increased 50% YoY to RM502 million.

  • Total equity rose to RM17.1 billion as at 31 December 2025; net assets per share increased to RM2.38 from RM2.25.

  • Major events included the conditional voluntary takeover offer for IJM Corporation Berhad and the proposed listing of Sunway Healthcare Holdings Berhad.

Financial highlights

  • Construction revenue surged 79.3% YoY to RM4.42 billion, with PBT up 89.5% to RM533.1 million, reflecting peak progress on data centre projects.

  • Property development revenue fell 26.1% YoY, but underlying PBT (excluding one-offs) rose 27.9% due to Sunway MCL/HLMCL acquisition and asset revaluation gains.

  • Healthcare segment's net profit was RM215.6 million (down 0.2% YoY), with underlying growth offset by start-up losses at new hospitals.

  • Trading & manufacturing revenue grew 28.5% YoY, PBT up 34.6%, led by automotive and equipment sales.

  • Net gearing ratio increased to 0.48x from 0.41x a year earlier; total borrowings rose to RM15.0 billion (31 Dec 2024: RM10.9 billion); cash and bank balances at RM6.8 billion (31 Dec 2024: RM4.3 billion).

Outlook and guidance

  • FY2026 earnings growth expected, supported by resilient domestic demand, robust investment, higher tourist spending, and major infrastructure projects.

  • Property launches targeted at RM4.8 billion and sales at RM4.2 billion for 2026; construction order book replenishment target raised to RM6.0 billion.

  • Healthcare segment to benefit from increased licensed beds and full-year EBITDA from new hospitals.

  • Focus remains on core businesses: property development, construction, and healthcare.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more